About Us

Learn about Lilium™, our science and the people
behind our innovative products.

Company overview

LILIUM

LILIUM produces biological cosmetic products to help your skin, hair, and body realize their potential and reveal your natural beauty.

All LILIUM products are manufactured by Neobiosis – a biotechnology company based on rigorous scientific research and ethical and moral integrity.

Our Goal is Simple:
To create topical cosmetics that reintroduce natural, non-animal-based, glycosaminoglycans and other basic building blocks lost by aged and aging skin of every type.

Our team

Chief scientific Officer
chief medical officer
brand president
partner development manager

Dr. Ian White

Dr. Ian White is an expert in the field of regenerative medicine and stem cell biology with over 20 years’ experience working in academia and industry. Dr. White received his B.S. from Liverpool John Moores University and his M.S. from the famed Liverpool School of Tropical Medicine in England prior to being hired at Dartmouth College in the United States to study the genetics of gamete biology. In August of 2000 Dr. White was recruited to Harvard University to work with hematopoietic stem cells (HSCs) and immune cell biology under the mentorship of the world-renowned Dr. Laurie Glimcher, where he co-authored several peer-reviewed scientific publications. Dr. White went on to receive his Ph.D. from the Ansary Stem Cell Institute, division of Regenerative Medicine at Cornell University under the guidance of Howard Hughes investigator Dr. Shahin Rafii. During this time Dr. White developed an in vitro method for culture expanding autologous HSCs in an artificial vascular niche for the treatment of cancer patients who have undergone bone marrow ablation following chemo- or radio-therapy. This technology has since gone on to be commercialized by Cornell and the company, Angiocrine, LLC, has become one of the top two HSC expansion companies in the US. Following the completion of his Ph.D., Dr. White spent time as a post-doctoral research scientist in the embryonic stem cell (ESC) laboratory of Dr. Stephen Dalton, whose pioneering work led to the inclusion of c-myc as one of the four factors used by Nobel award winning Dr. Shinya Yamanaka in the generation of induced pluripotent stem cells (iPSCs). Subsequently, Dr. White relocated to the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. Dr. White published ground-breaking research in the field of regenerative medicine alongside Dr. Joshua Hare, including a book chapter on the use of Mesenchymal Stem Cells (MSCs) in cardiac regeneration. In 2015, Dr. White’s work on the regeneration of the heart was featured on the cover of Circulation Research, one of the top peer-reviewed journals for cardiovascular medicine in the world. In 2016. Dr. White was honored with an award for the “Best Manuscript” by the American Heart Association for this work, which highlighted the role of peripheral nerves in cardiac regeneration. Dr. White has lectured and published extensively in the field of stem cell biology, clinical stem cell applications and regenerative medicine.

Dr. Pascal Goldschmidt MD

Neobiosis’s Chief Medical Officer, Dr. Pascal Goldschmidt MD is an accomplished cardiologist, professor, academic healthcare leader, and medical researcher. He has served as a Tenured Professor at three prestigious institutions, Duke University School of Medicine, Ohio State University (OSU) and University of Miami. He was Center Director at Johns Hopkins University School of Medicine (then OSU), Chief of Cardiology at OSU, then at Duke, and Chairman of Medicine at Duke. In 2006, he became Dean of the Miller School of Medicine and Founder/CEO of UHealth, the University of Miami Health System.

Trish Boyce

Trish Boyce has been working with Lilium™ Cosmetics since 2020. She was hired as Partner Development Manager in 2022 because of her passion for biologic-based products. Trish has a wealth of industry knowledge and 6 years of experience with medical devices and products derived from tissue, including PRP, PDO Threads, and Hyaluronic Acid. Trish looks forward to the future of biologic-based products and the field of Aesthetics.

FREQUENTLY ASKED questions

FAQs

Q. How are LILIUM biological ingredients sourced?

A. All LILIUM products contain biological ingredients sourced from donated, healthy human birth tissues collected from hospitals by US tissue banks in accordance with CDC, FDA, and US Organ Procurement and Transplantation Network policies. All donors sign an informed consent and have been screened for donor eligibility risks and infectious diseases by an independent, CLIA-certified laboratory based on American Association of Tissue Banks (AATB) standards for the collection of birth tissues.

Q. How are LILIUM products processed?

A. LILIUM products are processed by NEOBIOSIS laboratories using proprietary processes, which adhere to the standards established by the AATB and are in compliance with FDA regulations as defined in the Food, Drug, and Cosmetic Act.

Q. What does LILIUM do?

A. LILIUM cosmetics are abundant in the building blocks of life. Over time, our skin loses its youthfulness because it lacks the basic building blocks present in newborn skin. These include young, intact collagens, lipids, proteins, and most importantly, the glycosaminoglycans hyaluronic acid and chondroitin sulfate. As we progressively lose these components in our skin, we experience visible signs of aging. LILIUM is a natural source of these important components, direct from the youngest and most abundant source, birth tissues. Replenishing these building blocks helps enhance the appearance of aged and aging skin.

Q. What types of skin can benefit from LILIUM ?

A. Birth is universal. Every human develops in contact with amniotic fluid. The scientific literature describes how skin and other organs do not develop properly when there is insufficient amniotic fluid present. The components of amniotic fluid are required for the health and vitality of all types of skin (e.g. eyes, face, neck, elbows, etc.) and every ethnicity.

Q. Isn’t all hyaluronic acid (HA) the same?

A. No. While HA may be the #1 ingredient added to cosmetics like skin creams, it is harvested from rooster combs or extracted from the pathogenic bacterium streptococcus and then mixed into a compound. Using animal-derived HA or HA extracted from bacteria is far from ideal. At LILIUM, we have discovered a natural, abundant, renewable and safe source of HA, which was historically discarded as medical waste after birth. HA from amniotic fluid and Wharton’s jelly is a long-strand, human-compatible alternative to the HA currently on the market. LILIUM is revolutionizing the use of HA in cosmetics. We add nothing, and we take nothing away. LILIUM contains natural HA in abundance.

Office

Contact Us

305 SW 7th Terrace
Gainesville, FL 32601

Mon - Fri: 9am - 5pm
Sat - Sun: Closed

EMAIL
info@myliliumlife.com

Disclaimer

Lilium™ is not a drug product. It is not intended to prevent, treat, mitigate or cure any disease and is not intended to affect the structure or function of the body. Lilium™ is intended for topical use only. Lilium™ products are processed from amniotic fluid and Wharton’s jelly from birth tissues collected by tissue banks within the USA following AATB, FDA, and CDC guidelines.